ホームMCPワークベンチSkills
ホームワークベンチ通知マイページ
llms.txt · MCPガイドプライバシーポリシー · 利用規約 · サポートv1.8.0
  1. ホーム
  2. /反応

Thiazolo[4,5-c]pyridine → (6R)-7-[[(2Z)-2-(2-amino-1,3-thiazol-4-yl)-2-(1-carboxycyclobutyl)oxyiminoacetyl]amino]-8-oxo-3-([1,3]thiazolo[4,5-c]pyridin-5-ium-5-ylmethyl)-5-thia-1-azabicyclo[4.2.0]oct-2-ene-2-carboxylate

HRID 615790
ノート
印刷プレビュー

反応式

HRID 615790 の反応式
C([O:5][C:6]([C:8]1([O:12]/[N:13]=[C:14](/[C:45]2[N:46]=[C:47]([NH:50]C(C3C=CC=CC=3)(C3C=CC=CC=3)C3C=CC=CC=3)[S:48][CH:49]=2)\[C:15]([NH:17][CH:18]2[C:43](=[O:44])[N:20]3[C:21]([C:27]([O:29]C(C4C=CC=CC=4)C4C=CC=CC=4)=[O:28])=[C:22]([CH2:25]I)[CH2:23][S:24][C@H:19]23)=[O:16])[CH2:11][CH2:10][CH2:9]1)=[O:7])(C)(C)C.[S:70]1[C:78]2[CH:77]=[CH:76][N:75]=[CH:74][C:73]=2[N:72]=[CH:71]1>CS(C)=O.CCOCC>[NH2:50][C:47]1[S:48][CH:49]=[C:45](/[C:14](=[N:13]/[O:12][C:8]2([C:6]([OH:5])=[O:7])[CH2:11][CH2:10][CH2:9]2)/[C:15]([NH:17][CH:18]2[C:43](=[O:44])[N:20]3[C:21]([C:27]([O-:29])=[O:28])=[C:22]([CH2:25][N+:75]4[CH:76]=[CH:77][C:78]5[S:70][CH:71]=[N:72][C:73]=5[CH:74]=4)[CH2:23][S:24][C@H:19]23)=[O:16])[N:46]=1
参加物実験手順後処理出典と根拠反応ノート

参加物

5

反応物 2

HCID 585837Thiazolo[4,5-c]pyridineHCID 172953015benzhydryl (6R)-3-(iodomethyl)-7-[[(2Z)-2-[1-[(2-methylpropan-2-yl)oxycarbonyl]cyclobutyl]oxyimino-2-[2-(tritylamino)-1,3-thiazol-4-yl]acetyl]amino]-8-oxo-5-thia-1-azabicyclo[4.2.0]oct-2-ene-2-carboxylate

生成物 1

HCID 141546256(6R)-7-[[(2Z)-2-(2-amino-1,3-thiazol-4-yl)-2-(1-carboxycyclobutyl)oxyiminoacetyl]amino]-8-oxo-3-([1,3]thiazolo[4,5-c]pyridin-5-ium-5-ylmethyl)-5-thia-1-azabicyclo[4.2.0]oct-2-ene-2-carboxylate収率 31%

試薬・触媒・溶媒 2

HCID 679Dimethyl Sulfoxide溶媒HCID 3283Diethyl Ether溶媒

実験手順

To a solution of diphenylmethyl 7-[(Z)-2-(1-t-butoxycarbonylcyclobut-1-oxyimino)-2-(2-tritylaminothiazol-4-yl)-acetamido]-3-iodomethyl-3-cephem-4-carboxylate [VIIe'] (482 mg, 0.45 mmole) in 2 mL of DMSO was added thiazolo[4,5-c]pyridine (68 mg, 0.5 mmole) in one portion. The mixture was stirred for 45 minutes at room temperature. The reaction mixture was then diluted with ether (50 mL) and the precipitated oil was triturated in ether (4×50 mL). The precipitate was mixed with anisole (0.5 mL), trifluoroacetic acid (5 mL) and water (0.5 mL), and the mixture was stirred with ice cooling for 30 minutes and at room temperature for 1 hour, and then was concentrated under reduced pressure (<30° C.). The residue was triturated with isopropyl ether (100 mL), and the resulting precipitate was collected by filtration to afford 395 mg of crude title compound, as a yellow powder. The crude product (387 mg) was purified on an HP-20 column (100 mL). The eluate containing desired product, which was eluted with 50% methanol, was concentrated and lyophilized to give 80 mg (31%) of the title product (Ie) as a pale yellow amorphous powder. Mp >170° C. (dec.).

後処理

  1. customthe precipitated oil was triturated in ether (4×50 mL)
  2. additionThe precipitate was mixed with anisole (0.5 mL), trifluoroacetic acid (5 mL) and water (0.5 mL)
  3. stirringthe mixture was stirred with ice cooling for 30 minutes and at room temperature for 1 hour
  4. concentrationwas concentrated under reduced pressure (<30° C.)
  5. customThe residue was triturated with isopropyl ether (100 mL)
  6. filtrationthe resulting precipitate was collected by filtration
  7. customto afford 395 mg of crude title compound
  8. customThe crude product (387 mg) was purified on an HP-20 column (100 mL)
  9. additionThe eluate containing desired product, which
  10. washwas eluted with 50% methanol
  11. concentrationwas concentrated

出典と根拠

ORDレコード
ord-ae358299d736460b9bf4830f9cced679
出典データセット
uspto-grants-1985_02
DOI
10.6084/m9.figshare.5104873.v1
特許番号
US04500526

反応ノート

読み込み中…

このページの内容参加物実験手順後処理出典と根拠反応ノート